Reporting owner · Q3 2026 · CIK 1741987

Burnett Patrick: insider trades.

Burnett Patrick reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($466K), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
Burnett Patrick

Companies

CompanyRelationshipTransactions
Arcutis Biotherapeutics, Inc. (ARQT)Officer · See Remarks6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-19Arcutis Biotherapeutics, Inc.S1,697$27117,592Form 4
2026-08-12Arcutis Biotherapeutics, Inc.S6,700$26.08119,289Form 4
2026-08-12Arcutis Biotherapeutics, Inc.M6,700$3.64125,989Form 4
2026-08-11Arcutis Biotherapeutics, Inc.S8,300$26.52119,289Form 4
2026-08-11Arcutis Biotherapeutics, Inc.M8,300$3.64127,589Form 4
2026-08-03Arcutis Biotherapeutics, Inc.S955$26.12119,289Form 4

Questions

What stock did Burnett Patrick buy or sell?

Burnett Patrick reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($466K), across 1 company.

Is Burnett Patrick the same person as other filers with this name?

This page covers SEC CIK 1741987 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/burnett-patrick-1741987.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.